Working… Menu

A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03548220
Recruitment Status : Completed
First Posted : June 7, 2018
Last Update Posted : November 10, 2020
Information provided by (Responsible Party):
Agios Pharmaceuticals, Inc.